Serum chemerin levels: A potential biomarker of joint inflammation in women with rheumatoid arthritis

Abstract

Higher chemerin levels increased the risk of moderate and severe disease activity in RA. These results support the role of chemerin as a marker of inflammation in RA. Follow-up studies will identify if maintaining low chemerin levels can be used as a therapeutic target.